In this report, we have brought together highlights on how we are advancing our work in HIV, TB and malaria, with 14 exemplary case studies that illustrate some of our contributions to support the elimination of these diseases. We have the opportunity to achieve the SDGs over the next 11 years, requiring increased collaborations across...
Read more
New York, 23 September 2019: IFPMA congratulates the United Nations General Assembly in holding the first-ever high-level meeting on Universal Health Coverage (UHC) and welcomes the adoption of the Political Declaration on UHC at its 74th session. IFPMA and its members welcome the declaration’s call to address healthcare in a holistic way and the elevation...
Read moreAs world leaders meet at the United Nations General Assembly to discuss the “Universal Health Coverage: Moving Together to Build a Healthier World” which aims to accelerate progress toward universal health coverage, Dr. Angela Nyambura Gichaga, Chief Executive Officer, the Financing Alliance for Health (FAH) explains how partnerships can help governments make the most of...
Read moreThis publication builds on our industry’s eight guiding principles on universal health coverage (UHC), developed in 2014, including our views on the key ingredients required for achieving UHC, and reaffirms our commitment to play our part. But before we can pave the way forward, we must first address why it is now more critical than ever to rise to this challenge.
Read more
The biopharmaceutical industry is experiencing intense changes with a number of frontier technologies impacting the way it does research, the way it commercializes its products and collaborates with partners and stakeholders across the world to save lives and improve access to patients. This video series, hosted by Julien Durand, Chair of the IFPMA Future Health...
Read moreRead more
Lessons learned from international best practice in policy and programming.
Read more
GENEVA, 12 September 2019 – The report “Implementing a Life-Course Approach to Immunization” provides a policy framework for countries to implement effective policies in order to maximize individual and population-wide health and economic benefits of a life-course approach to immunization. A life-course approach requires that immunization schedules and access to vaccination respond to an individual’s stage...
Read moreGENEVA, 10 SEPTEMBER 2019: IFPMA is proud to be a key partner of the Business Ethics for APEC SMEs initiative, the largest public-private partnership of its kind in the world with participation from more than 1,250 organizations across all 21 APEC member economies all working towards achieving ethics and integrity in the service of patients...
Read morePaola Barbarino, Chief Executive Officer at Alzheimer’s Disease International (ADI), talks to IFPMA about changing attitudes and perceptions surrounding dementia and Alzheimer’s. Is mental health getting enough attention in the UHC discussions and what are your hopes for the upcoming UN High Level Meeting on UHC? Following on from the High-Level Meeting on Non-Communicable Diseases...
Read moreGENEVA, 2 September 2019 – Today, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launched a new report titled ‘Complex Journey of a Vaccine: The Steps behind Developing a New Vaccine’. The report highlights three major factors that contribute to the lengthy development process of a novel vaccine, and highlights the challenges that manufacturers...
Read more